Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianjiang Fu

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Molecular Biosystems|June 21, 2007
Transcriptomic signatures in breast cancerJianjiang Fu, Stefanie S Jeffrey
Cancer Letters|October 10, 2006
The retinoid X receptor-selective ligand, LGD1069, inhibits tumor-induced angiogenesis via suppression of VEGF in human non-small cell lung cancerJianjiang Fu, Yan Ding, Dan Huang, et al.
BMC Cancer|June 9, 2011
In vitro anti-angiogenic properties of LGD1069, a selective retinoid X-receptor agonist through down-regulating Runx2 expression on Human endothelial cellsJianjiang Fu, Wei Wang, Yu-Hui Liu, et al.
International Journal of Oncology|October 16, 2018
Curcolonol suppresses the motility of breast cancer cells by inhibiting LIM kinase 1 to downregulate cofilin 1 phosphorylationHong Lu, Jie Chen, Yongming Luo, et al.
Molecular Biology Reports|April 26, 2020
Role of PI3K/AKT pathway in cancer: the framework of malignant behaviorNingni Jiang, Qijie Dai, Xiaorui Su, et al.
Cancers|February 15, 2022
The Landscape of PDK1 in Breast CancerNa Wang, Jianjiang Fu, Zhihua Li, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|September 16, 2018
In vitro inhibitory properties of sesquiterpenes from Chloranthus serratus on cell motility via down-regulation of LIMK1 activation in human breast cancerJianjiang Fu, Juanjuan Yu, Jie Chen, et al.
International Journal of Oncology|August 4, 2023
Artificial intelligence in cancer pathology: Challenge to meet increasing demands of precision medicineBoan Lai, Jianjiang Fu, Qingxin Zhang, et al.
Oncogene|June 19, 2021
HGF/c-MET pathway in cancer: from molecular characterization to clinical evidenceJianjiang Fu, Xiaorui Su, Zhihua Li, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|September 27, 2015
The natural compound codonolactone impairs tumor induced angiogenesis by downregulating BMP signaling in endothelial cellsShan Wang, Rui Cai, Junchao Ma, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Molecular Biosystems|June 21, 2007
Transcriptomic signatures in breast cancerJianjiang Fu, Stefanie S Jeffrey
Cancer Letters|October 10, 2006
The retinoid X receptor-selective ligand, LGD1069, inhibits tumor-induced angiogenesis via suppression of VEGF in human non-small cell lung cancerJianjiang Fu, Yan Ding, Dan Huang, et al.
BMC Cancer|June 9, 2011
In vitro anti-angiogenic properties of LGD1069, a selective retinoid X-receptor agonist through down-regulating Runx2 expression on Human endothelial cellsJianjiang Fu, Wei Wang, Yu-Hui Liu, et al.
International Journal of Oncology|October 16, 2018
Curcolonol suppresses the motility of breast cancer cells by inhibiting LIM kinase 1 to downregulate cofilin 1 phosphorylationHong Lu, Jie Chen, Yongming Luo, et al.
Molecular Biology Reports|April 26, 2020
Role of PI3K/AKT pathway in cancer: the framework of malignant behaviorNingni Jiang, Qijie Dai, Xiaorui Su, et al.
Cancers|February 15, 2022
The Landscape of PDK1 in Breast CancerNa Wang, Jianjiang Fu, Zhihua Li, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|September 16, 2018
In vitro inhibitory properties of sesquiterpenes from Chloranthus serratus on cell motility via down-regulation of LIMK1 activation in human breast cancerJianjiang Fu, Juanjuan Yu, Jie Chen, et al.
International Journal of Oncology|August 4, 2023
Artificial intelligence in cancer pathology: Challenge to meet increasing demands of precision medicineBoan Lai, Jianjiang Fu, Qingxin Zhang, et al.
Oncogene|June 19, 2021
HGF/c-MET pathway in cancer: from molecular characterization to clinical evidenceJianjiang Fu, Xiaorui Su, Zhihua Li, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|September 27, 2015
The natural compound codonolactone impairs tumor induced angiogenesis by downregulating BMP signaling in endothelial cellsShan Wang, Rui Cai, Junchao Ma, et al.
Pageof 3